In the News

484 News Items found
Graphic showing 11 cancer drugs approved by the FDA based on significant work done at MSK
The U.S. Food and Drug Administration (FDA) approved 11 cancer drugs in 2024 based on significant contributions from MSK researchers.
Group of Black men posing at prostate cancer fundraising walk.
A Black community leader seeks prompt treatment for prostate cancer, avoiding the harsh toll the disease often takes on men like him.
A researcher working in an MSK lab
MSK Research Highlights, March 28, 2024
New MSK research helps win the approval of a drug to treat one type of metastatic non-small cell lung cancer; shows the effectiveness of cryoablation for large breast cancer tumors; identifies a gene essential for the formation of a common childhood brain tumor; and unlocks the secrets of natural killer cell metabolism.
Angela Katrichis speaks with a patient
Ask the Expert
Learn how to cope with stress and anxiety you may feel if you are diagnosed with cancer and your doctor recommends active surveillance instead of treatment.
Susan Everson, a transgender woman, was treated at MSK for stage 3 colorectal cancer. She says her care team made her feel welcome, in addition to offering her the most advanced therapies. Susan is now cancer free.
Learn how MSK cares for transgender cancer patients, treating them with respect and medical expertise. Staff are specially trained to understand their needs.
MSK-IMPACT
Fifty years ago, the signing of the National Cancer Act ushered in a new era of cancer research and care.
whole fresh turmeric root beside a bowl of turmeric powder
The Truth About Turmeric and Cancer
Can turmeric fight cancer? Learn more from an MSK expert about what the science says.
Dr. Simon Powell
Feature
Experts from MSK shared their work in more than 40 presentations and poster sessions at the 2023 meeting of ASTRO, the American Society for Therapeutic Radiology and Oncology.
A female nurse talks with a female patient, who is sitting in an exam chair
Feature
Advances in diagnosis and treatment, especially those made over the past ten years, have played a significant role in the decline in cancer deaths. Learn about those advances — and what to expect in the next ten years.
Computational biologist Barry Taylor
Finding
Sometimes a BRCA mutation is just along for the ride, rather than driving a tumor’s development.